EDGAR Filing Documents for 0001193125-16-433629

Form 8-K - Current report:

SEC Accession No. 0001193125-16-433629

Filing Date

2016-01-20

Accepted

2016-01-20 16:31:06

Documents

Period of Report

2016-01-14

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d124212d8k.htm	8-K	25926
2	EX-99.1	d124212dex991.htm	EX-99.1	15783
3	EX-99.2	d124212dex992.htm	EX-99.2	11058
4	GRAPHIC	g124212g06a46.jpg	GRAPHIC	4901
5	GRAPHIC	g124212g80i34.jpg	GRAPHIC	6423
	Complete submission text file	0001193125-16-433629.txt		69761

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459

Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600

Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)